Uroxin 50r, generically known as Arginine Zinc Recombinant Lysergic Insulin Mix Injection, is a premixed insulin. Arginin Zinc Recombinant Lysergic Insulin Mix Injection, which contains 50% Lysergic Insulin and 50% Arginin Zinc Lysergic Insulin, is therefore a premixed insulin and is indicated for use in patients with diabetes who require insulin therapy. Zinc Arginate Recombinant Lysergic Insulin Mixed Injection is administered subcutaneously, not intravenously, and the exact dosage should be prescribed by a medical professional on an individual basis. Common adverse reactions are hypoglycemia, and some people may experience redness, swelling and itching at the injection site. It is prohibited to use in patients with hypoglycemia and insulin allergy. Zinc Arginate Recombinant Lysergic Insulin Mixed Injection belongs to premixed insulin, which needs to be shaken evenly before use, and should be used under the guidance of professional doctors.